USPTO Publishes Additional Subject Matter Eligibility Guidance – AI Technology On Tuesday, July 16, 2024, the United States Patent and Trademark Office (USPTO) published the 2024 Guidance Update on Patent…
In the Reuters Legal article “Fair Play, Trademarks and Sponsorships: How to Navigate the Olympics Season,” partners Jonathan Hyman and Jeff Van Hoosear offer helpful guidelines to brands for marketing…
In the latest installment of their monthly Law360 column on recent noteworthy Federal Circuit decisions, partners Sean Murray and Jeremiah Helm examine the “fundamental shift in intellectual property law” resulting…
In the article “Surfing and Skiing Make Me a Better Lawyer,” part of Law360’s “My Hobby Makes Me a Better Lawyer” expert analysis series, litigation partner Brian Claassen offers insight…
In the QSR article “Inside Momofuku’s Battle Over ‘Chili Crunch’ Trademark,” Knobbe Martens lawyers Alexander Zeng, Brandon Hupka and Jonathan Hyman discuss the evolution of Momofuku’s trademark enforcement strategy. Through the lens of trademark law,…
In the latest installment of Knobbe Martens’ monthly Law360 column focused on recent noteworthy Federal Circuit decisions, partners Jeremiah Helm and Sean Murray discuss the precedential opinion recently issued in…
In a recent Cannabis Business Executive article, associate Jacob Golan and partners Jonathan Hyman and Jonathan Menkes, both of whom co-chair Knobbe Martens’ CBD & legal cannabis practice, explore the…
In the Reuters Legal article “Drake and the Emergence of AI in Creative Expression,” associate Matt Pham and partner Baraa Kahf analyze the legal questions raised by rapper Drake’s use…
Knobbe Martens partner and advertising & media practice co-chair Jonathan Hyman and associate Nickolas Taylor have authored the article “Social Media and the Law—A Warning for Brands and Content Creators,”…
In the latest installment of Knobbe Martens’ monthly column focused on recent noteworthy Federal Circuit decisions, partners Sean Murray and Jeremiah Helm examine the outcome of Salix Pharmaceuticals v. Norwich Pharmaceuticals….
